Organ Donation Law in Bangladesh
An overview of Bangladesh’s organ‑donation framework, key legal features and practical considerations for international stakeholders, with a comparative note on England and Wales regulatory approaches.
London — Holborn Gate, 330 High Holborn, London, WC1V 7QH. This note summarises the statutory framework and systemic issues affecting organ donation in Bangladesh and highlights comparative points that may be relevant to international health organisations, regulators and investors engaging in the region. It is descriptive in nature and intended for an informed audience.
Overview of the legal framework and practical effects
Bangladesh’s primary statute addressing organ transplantation is commonly cited as Act No. 05 of 1999. The Act establishes criminal and regulatory controls intended to prevent organ trafficking and unauthorised transplants. In practice, the law’s definition of permissible donors — often limited to a narrow class of “close relatives” — and weaknesses in institutional capacity have contributed to a persistent gap between demand for transplants and legally available supply. That gap has been associated with informal markets and challenges in equitable allocation.
Key legal and governance issues
Several recurring themes appear in analysis of the Bangladeshi regime:
- Donor eligibility: a restricted donor definition reduces the pool of permissible living donors and constrains development of deceased‑donation programmes.
- Regulatory oversight: effective licensing, transplant registries and post‑operative follow up require resources and institutional independence that are often limited.
- Enforcement and anti‑trafficking: criminal provisions exist, but detection and cross‑border cooperation are challenging; opaque commercial arrangements can facilitate illicit activity.
- Ethical and consent safeguards: robust consent processes, protection of vulnerable donors and transparency in allocation are essential to public trust and to prevent exploitation.
Comparative perspective: England and Wales
For comparison, England and Wales operate under a statutory framework that separates consent/authorisation rules, criminal offences for organ trade and an independent regulator. The Human Tissue Act 2004 and subsequent legislation establishing a deemed‑consent (opt‑out) system for deceased donation altered supply dynamics, supported by NHS Blood and Transplant (NHSBT) and oversight by the Human Tissue Authority in related areas. These instruments are embedded in well‑resourced NHS structures and a national allocation system — features that shape outcomes and may be instructive when considering reforms elsewhere.
Practical checklist for international stakeholders
When evaluating involvement in transplantation systems or health projects connected to Bangladesh, consider the following high‑level checks:
- Regulatory due diligence: map applicable statutes, licensing regimes and enforcement mechanisms.
- Risk assessment: identify potential trafficking, corruption or reputational risks linked to supply constraints.
- Local partnerships: prioritise collaboration with public health bodies, accredited hospitals and civil society.
- Capacity building: support registries, training in ethical consent procedures and long‑term follow up capacity.
- Compliance and governance: ensure contracts and clinical pathways include robust safeguards and audit provisions.
Jurisdiction and sources
- Government of the People’s Republic of Bangladesh — Ministry of Health and Family Welfare
- Relevant legislation: Act No. 05 of 1999 (transplantation/organ donation statute) and accompanying rules published in the Bangladesh Gazette
- United Kingdom: Human Tissue Act 2004; Organ Donation (Deemed Consent) Act 2019; Human Tissue Authority; NHS Blood and Transplant
General information only; not legal advice and not a substitute for advice on a particular matter.
Bring the question into focus.
Contact the London office with a high-level, non-confidential outline of the issue. We can discuss the appropriate next step.